{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CHF", "regularMarketChangePercent": 1.5025069, "regularMarketPrice": 6.08, "exchange": "CXE", "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "marketState": "CLOSED", "esgPopulated": false, "sharesOutstanding": 0, "bookValue": 7.226, "fiftyDayAverage": 5.921765, "fiftyDayAverageChange": 0.15823507, "fiftyDayAverageChangePercent": 0.026720932, "twoHundredDayAverage": 5.921765, "twoHundredDayAverageChange": 0.15823507, "twoHundredDayAverageChangePercent": 0.026720932, "marketCap": 220322176, "priceToBook": 0.84140605, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1681887600000, "priceHint": 2, "regularMarketChange": 0.09000015, "regularMarketTime": 1683904651, "regularMarketDayHigh": 6.12, "regularMarketDayRange": "6.06 - 6.12", "regularMarketDayLow": 6.06, "regularMarketVolume": 1322, "regularMarketPreviousClose": 5.99, "bid": 6.01, "ask": 0.0, "fullExchangeName": "Cboe UK", "financialCurrency": "CHF", "regularMarketOpen": 6.1, "averageDailyVolume3Month": 1422, "averageDailyVolume10Day": 1467, "fiftyTwoWeekLowChange": 0.50999975, "fiftyTwoWeekLowChangePercent": 0.09156189, "fiftyTwoWeekRange": "5.57 - 6.16", "fiftyTwoWeekHighChange": -0.07999992, "fiftyTwoWeekHighChangePercent": -0.012987001, "fiftyTwoWeekLow": 5.57, "fiftyTwoWeekHigh": 6.16, "earningsTimestamp": 1683813600, "earningsTimestampStart": 1683813600, "earningsTimestampEnd": 1683813600, "trailingAnnualDividendRate": 0.0, "trailingPE": 1.7175142, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 3.54, "symbol": "MOLNZ.XC"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Molecular Partners AG operates as a clinical-stage biopharmaceutical company, develops ankyrin proteins for the treatment of oncology and virology diseases. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration, as well as for diabetic macular edema; and ensovibep (MP0420), a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, a DARPin molecule, which activates T-cells and other immune cells; MP0317, that allows tumor-restricted immune-cell CD40 activation for the treatment of fibroblast activation protein (FAP) positive cancers, which is in Phase I clinical trials; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274, that uses HER2-specific DARPin binding proteins. It also develops MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor (VEGF)and hepatocyte growth factor. Molecular Partners AG has license and research collaboration agreements with Novartis AG to develop DARPin-conjugated radioligand therapies, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 175, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 47, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 620000, "fmt": "620k", "longFmt": "620,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 50, "title": "Co-Founder, Exec. VP of Projects & Member of Management Board", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 47, "title": "COO & Member of Management Board", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nicolas  Leupin M.B.A., Ph.D., M.D., MBA", "age": 49, "title": "Chief Medical Officer & Member of Management Board", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 52, "title": "Exec. VP of People & Community and Member of Management Board", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Sr. VP of Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Sr. VP of Investor Relations, Communications & Strategy", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "Gen. Counsel, Compliance Officer & Sr. VP of Legal", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pamela A. Trail", "age": 66, "title": "Strategic Consultant", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anne  Goubier D.V.M., Ph.D.", "title": "Sr. VP of Biology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}